跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HERCEPTIN 600 MG SOLUCION INYECTABLE EN VIAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
HERCEPTIN 600 MG SOLUCION INYECTABLE EN VIAL
Approved
STANDARD
HERCEPTIN 600 MG SOLUCION INYECTABLE EN VIAL
Roche Registration Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 29, 2024
Approval ID
eb9944d227062875
Company
Roche Registration Gmbh
Type
Standard
Approval Details
Approval Id
eb9944d227062875
Drug Cima Aemps Name
HERCEPTIN 600 MG SOLUCION INYECTABLE EN VIAL
Register Number
100145002IP1
Holder Company Name
Roche Registration Gmbh
Marketing Company Name
Difarmed S.L.U.
Holder Company Detail Path
/organization/roche-registration-gmbh
Authorization Date
2024-05-29
Dosage Form
SOLUCIÓN INYECTABLE
Dose
600 mg/5 ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Roche Registration Gmbh
Company Detail Path
/organization/roche-registration-gmbh
Company Information
Pharmaceutical Company Name
Roche Registration GmbH
Country Name
Germany
City Name
grenzach-wyhlen,baden-württemberg,country_de
Address
Emil-Barell-Str. 1
Active Ingredients
TRASTUZUMAB
600 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 29, 2024
Approval ID
eb9944d227062875
Type
Standard
Back to CIMA-AEMPS Approvals
